LINC00662 Promotes Proliferation and Invasion and Inhibits Apoptosis of Glioma Cells Through miR-483-3p/SOX3 Axis

被引:0
作者
Lei Yuan
Pengqi Zhang
Youming Lu
Aijun Zhang
Xin Chen
机构
[1] Shanghai Jiaotong University,Department of Neurosurgery, the Affiliated Sixth People’s Hospital
来源
Applied Biochemistry and Biotechnology | 2022年 / 194卷
关键词
LINC00662; Glioma; miR-483-3p; SOX3;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2857 / 2871
页数:14
相关论文
共 110 条
  • [1] Ostrom QT(2014)The epidemiology of glioma in adults: A “state of the science” review Neuro-oncology 16 896-913
  • [2] Bauchet L(2010)Primary spinal cord glioma: A surveillance, epidemiology, and end results database study Journal of neuro-oncology 98 83-92
  • [3] Davis FG(2019)Long noncoding RNA expression profiling in cancer: Challenges and opportunities Genes, chromosomes & cancer 58 191-199
  • [4] Milano MT(2020)Long noncoding RNA NEAT1 suppresses proliferation and promotes apoptosis of glioma cells via downregulating miR-92b Cancer Control 27 1073274819897977-395
  • [5] Johnson MD(2019)Long non-coding RNA LINC00174 promotes glycolysis and tumor progression by regulating miR-152-3p/SLC2A1 axis in glioma Journal of experimental & clinical cancer research : CR 38 395-3940
  • [6] Sul J(2018)LncRNA MALAT1/miR-129 axis promotes glioma tumorigenesis by targeting SOX2 Journal of cellular and molecular medicine 22 3929-469
  • [7] Lorenzi L(2018)Long non-coding RNA Linc00662 promotes cell invasion and contributes to cancer stem cell-like phenotypes in lung cancer cells J Biochem 164 461-3698
  • [8] Avila Cobos F(2019)Linc00662 promotes tumorigenesis and progression by regulating miR-497-5p/AVL9 axis in colorectal cancer Frontiers in genetics 10 1385-656
  • [9] Decock A(2019)Long noncoding RNA LINC00662 functions as miRNA sponge to promote the prostate cancer tumorigenesis through targeting miR-34a European review for medical and pharmacological sciences 23 3688-776
  • [10] Liu D(2019)Long non-coding RNA LINC00662 promotes proliferation and migration in oral squamous cell carcinoma OncoTargets and therapy 12 647-1284